Ultrasound rock salt aerosol trial for lung health
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new ultrasound rock salt aerosol inhalation treatment to see how well it reaches the lungs. It may help people with chronic airway diseases who need nebulizer therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult or have a chronic lung condition like asthma or COPD
- You are 18 years or older
- You are not on a breathing machine or have a breathing tube
- You do not have serious liver or kidney damage
- You are not allergic to radioactive materials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ensifentrine, given through a nebulizer, to see if it changes inflammation-related substances found in mucus/phlegm in people with COPD. It may help doctors understand whether this treatment improves COPD biology and could lead to better symptom control.
This is an early-stage study testing a new inhaled medication (HRS-9821) to see if it is safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with COPD (chronic lung disease) to understand if it might help with breathing.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This trial tests whether an inhaled medication called HRS-9821 can help people with moderate to severe COPD (chronic obstructive pulmonary disease) breathe better and reduce symptoms. You inhale the medication, and researchers will measure how well your lungs work and how you feel over time.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
This study uses ultrasound and sensors to monitor lung health in people with certain lung conditions, including those that cause scarring or breathing problems. It aims to find better ways to track lung disease, which could help manage your condition more effectively.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.